Literature DB >> 23158187

Should patients with Cowden syndrome undergo prophylactic thyroidectomy?

Mira Milas1, Jessica Mester, Rosemarie Metzger, Joyce Shin, Jamie Mitchell, Eren Berber, Allan E Siperstein, Charis Eng.   

Abstract

BACKGROUND: Cowden syndrome (CS) is dominantly inherited and predisposes patients to tumors in multiple organs. We characterized CS-associated malignant and benign thyroid disease.
METHODS: Of data from 3,477 prospectively recruited CS patients with known genetic analysis, we analyzed 225 PTEN mutation+ patients whose treatment occurred at our center (n = 25) or other hospitals nationwide (n = 200).
RESULTS: A total of 32 of 225 PTEN mutation+ patients (14%) had thyroid cancer: 52% papillary, 28% follicular-variant papillary, 14% follicular, and 6% anaplastic. Median age at diagnosis was 35 years compared with 49 years for Surveillance Epidemiology and End Results population data. Initial thyroid ultrasonography in 16 of 25 patients revealed thyroiditis/goiters in all >13 years age, leading to FNA in 7 (64%), thyroidectomy in 3 (27%), and new cancer diagnosis in 2 (18%). Three with severe autism required intraoperative sedation for ultrasonography. A total of 9 of 25 patients were monitored after multiple partial thyroidectomies for goiters by age 42 (n = 5), thyroiditis, or cancer detected by age 36 (n = 3).
CONCLUSION: PTEN mutation+ patients with CS have an enormous prevalence of thyroid disease. Earlier screening may be advisable because thyroiditis and nodules are seen by the time patients reach adolescence, and cancer diagnosis occurs on average 14 years earlier than expected. Furthermore, the risks observed may justify prophylactic total thyroidectomy in select, if not all, patients, particularly those with developmental disorders.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158187     DOI: 10.1016/j.surg.2012.08.055

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

2.  Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS).

Authors:  Michaela Plamper; Felix Schreiner; Bettina Gohlke; Janina Kionke; Eckard Korsch; James Kirkpatrick; Mark Born; Stefan Aretz; Joachim Woelfle
Journal:  Eur J Pediatr       Date:  2017-12-22       Impact factor: 3.183

Review 3.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

Review 4.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.

Authors:  Amanda K Tilot; Thomas W Frazier; Charis Eng
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

5.  Considerations for total thyroidectomy in an adolescent with PTEN mutation.

Authors:  Mustafa Tosur; Mary L Brandt; Ioanna D Athanassaki; Surya P Rednam
Journal:  Ther Adv Endocrinol Metab       Date:  2018-07-04       Impact factor: 3.565

6.  A Case Report of Syndromic Multinodular Goitre in Adolescence: Exploring the Phenotype Overlap between Cowden and DICER1 Syndromes.

Authors:  Dorothée Bouron-Dal Soglio; Leanne de Kock; Richard Gauci; Nelly Sabbaghian; Elizabeth Thomas; Helen C Atkinson; Nicholas Pachter; Simon Ryan; John P Walsh; M Priyanthi Kumarasinghe; Karen Carpenter; Ayça Aydoğan; Colin J R Stewart; William D Foulkes; Catherine S Choong
Journal:  Eur Thyroid J       Date:  2017-11-21

7.  The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance.

Authors:  Julia A Baran; Steven D Tsai; Amber Isaza; Garrett M Brodeur; Suzanne P MacFarland; Kristin Zelley; Denise M Adams; Aime T Franco; Andrew J Bauer
Journal:  Horm Res Paediatr       Date:  2021-04-22       Impact factor: 2.852

Review 8.  Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.

Authors:  Benjamin Chevalier; Hippolyte Dupuis; Arnaud Jannin; Madleen Lemaitre; Christine Do Cao; Catherine Cardot-Bauters; Stéphanie Espiard; Marie Christine Vantyghem
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-06       Impact factor: 5.555

9.  Occurrence and Natural History of Thyroid Cancer in Patients with Cowden Syndrome.

Authors:  Thomas Szabo Yamashita; Fady J Baky; Travis J McKenzie; Geoffrey B Thompson; David R Farley; Melanie L Lyden; Benzon M Dy
Journal:  Eur Thyroid J       Date:  2020-03-12

Review 10.  Recommendations on Surveillance for Differentiated Thyroid Carcinoma in Children with PTEN Hamartoma Tumor Syndrome.

Authors:  L A Jonker; C A Lebbink; M C J Jongmans; R A J Nievelstein; J H M Merks; E J M Nieveen van Dijkum; T P Links; N Hoogerbrugge; A S P van Trotsenburg; H M van Santen
Journal:  Eur Thyroid J       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.